🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to see whether Axitinib will help prolong...
Status
Completed
Location
University of California San Francisco (UCSF)
Start Date
2011-10-25
Trial ID
NCT01435122
Treatments Being Tested
Introduction: This document explains a clinical research study conducted a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07159191
Treatments Being Tested
Primary Objective: To determine the response rate (RR) of metastatic or lo...
Status
Active Not Recruiting
Location
Columbia University Irving Medical Center
Start Date
2019-01-22
Trial ID
NCT03839498
Treatments Being Tested
The purpose is to show that 5 mg Form IV tablet of AG-013736 produces simil...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-01
Trial ID
NCT01020136
The hypothesis of this study is that one 5 mg tablet of axitinib has simila...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-07
Trial ID
NCT00905814
To determine the best dose of this investigational agent AG-013736 in combi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-12
Trial ID
NCT00454649
Treatments Being Tested
To allow continuation of axitinib (AG 013736) treatment to patients experie...
Status
Completed
Location
UC Irvine Medical Center
Start Date
2003-03-07
Trial ID
NCT00828919
Treatments Being Tested
The study is designed to demonstrate that axitinib plus best supportive car...
Status
Completed
Location
Alta Bates Summit Comprehensive Cancer Center
Start Date
2010-12-06
Trial ID
NCT01210495
Treatments Being Tested
A-PREDICT is a study of axitinib in patients with metastatic renal cell car...
Status
Completed
Location
Royal Surrey County Hospital
Start Date
2012-10
Trial ID
NCT01693822
Treatments Being Tested
Phase 1b/Phase 2 Umbrella Study; open-label, multi-center, parallel group s...
Status
Terminated
Location
City of Hope Investigational Drug Services (IDS)
Start Date
2020-11-10
Trial ID
NCT04585815
Treatments Being Tested